Literature DB >> 8406448

C4BPAL1, a member of the human regulator of complement activation (RCA) gene cluster that resulted from the duplication of the gene coding for the alpha-chain of C4b-binding protein.

P Sánchez-Corral1, F Pardo-Manuel de Villena, J Rey-Campos, S Rodríguez de Córdoba.   

Abstract

The regulator of complement activation (RCA) gene cluster evolved by multiple gene duplications to produce a family of genes coding for proteins that collectively control the activation of the complement system. We report here the characterization of C4BPAL1, a member of the human RCA gene cluster that arose from the duplication of the C4BPA gene after the separation of the rodent and primate lineages. C4BPAL1 maps 20 kb downstream of the C4BPA gene and is the same 5' to 3' orientation found for all RCA genes characterized thus far. It includes nine exon-like regions homologous to exons 2-8, 11, and 12 of the C4BPA gene. Analysis of the C4BPAL1 sequence suggests that it is currently a pseudogene in humans. However, comparisons between C4BPAL1 and the human and murine C4BPA genes show sequence conservation, which strongly suggests that, for a long period of time, C4BPAL1 has been a functional gene coding for a protein with structural requirements similar to those of the alpha-chain of C4b-binding protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406448     DOI: 10.1006/geno.1993.1300

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  C4BPAL2: a second duplication of the C4BPA gene in the human RCA gene cluster.

Authors:  F Pardo-Manuel de Villena; S Rodríguez de Córdoba
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Expression of the human gene coding for the alpha-chain of C4b-binding protein, C4BPA, is controlled by an HNF1-dependent hepatic-specific promoter.

Authors:  N Arenzana; S Rodríguez de Córdoba; J Rey-Campos
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.